Viemed Healthcare
VMD
141 hedge funds and large institutions have $202M invested in Viemed Healthcare in 2024 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 45 increasing their positions, 28 reducing their positions, and 8 closing their positions.
800% more call options, than puts
Call options by funds: $18K | Put options by funds: $2K
275% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 8
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
61% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 28
17% more funds holding
Funds holding: 121 → 141 (+20)
9% more capital invested
Capital invested by funds: $186M → $202M (+$16.2M)
0.33% less ownership
Funds ownership: 64.92% → 64.59% (-0.33%)
Top Buyers
Top Sellers
VMD Hedge Fund Activity: Q4 2024 in Review
141 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q4 2024, worth a combined $202M — up 8.7% from $186M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new VMD positions and 8 closed out — a net gain of 22 holders — while 45 added to existing stakes and 28 trimmed.
The largest buyer was Divisadero Street Capital Management, adding an estimated $2.57M. The largest seller was Wasatch Advisors, cutting an estimated $4.52M.
- 141 institutional investors held Viemed Healthcare (VMD) as of Q4 2024, up from 121 in Q3 2024.
- Funds reported $202M of Viemed Healthcare stock for Q4 2024, up 8.7% quarter-over-quarter.
- 30 funds opened new Viemed Healthcare positions in Q4 2024 and 8 closed out, a net change of +22 holders.
- The largest Viemed Healthcare buyer in Q4 2024 was Divisadero Street Capital Management, an estimated $2.57M added.
- The largest Viemed Healthcare seller in Q4 2024 was Wasatch Advisors, an estimated $4.52M sold.
Based on aggregated 13F filings for Q4 2024.